These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 32252024
1. miR-188 promotes liver steatosis and insulin resistance via the autophagy pathway. Liu Y, Zhou X, Xiao Y, Li C, Huang Y, Guo Q, Su T, Fu L, Luo L. J Endocrinol; 2020 Jun; 245(3):411-423. PubMed ID: 32252024 [Abstract] [Full Text] [Related]
2. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease. Liu X, Chen S, Zhang L. Am J Physiol Endocrinol Metab; 2020 Jul 01; 319(1):E34-E42. PubMed ID: 32228319 [Abstract] [Full Text] [Related]
3. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans. Bai J, Xia M, Xue Y, Ma F, Cui A, Sun Y, Han Y, Xu X, Zhang F, Hu Z, Liu Z, Liu Y, Cai G, Su W, Sun X, Wu H, Yan H, Chang X, Hu X, Bian H, Xia P, Gao J, Li Y, Gao X. EBioMedicine; 2020 Jul 01; 57():102849. PubMed ID: 32580141 [Abstract] [Full Text] [Related]
4. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator. Zhuge B, Li G. Biochem Biophys Res Commun; 2017 Dec 16; 494(3-4):687-692. PubMed ID: 29107687 [Abstract] [Full Text] [Related]
5. MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease. Xu M, Zheng XM, Jiang F, Qiu WQ. J Cell Biochem; 2018 Jul 16; 119(7):5864-5874. PubMed ID: 29575055 [Abstract] [Full Text] [Related]
6. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation. Kim YS, Nam HJ, Han CY, Joo MS, Jang K, Jun DW, Kim SG. Hepatology; 2021 Apr 16; 73(4):1307-1326. PubMed ID: 32557804 [Abstract] [Full Text] [Related]
7. Defective FXR-SHP Regulation in Obesity Aberrantly Increases miR-802 Expression, Promoting Insulin Resistance and Fatty Liver. Seok S, Sun H, Kim YC, Kemper B, Kemper JK. Diabetes; 2021 Mar 16; 70(3):733-744. PubMed ID: 33328206 [Abstract] [Full Text] [Related]
8. A negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteatosis in mice treated with a high fat diet. Zhang T, Zhao X, Steer CJ, Yan G, Song G. Metabolism; 2018 Aug 16; 85():183-191. PubMed ID: 29625129 [Abstract] [Full Text] [Related]
9. Dysregulation of microRNA-125a contributes to obesity-associated insulin resistance and dysregulates lipid metabolism in mice. Liu R, Wang M, Li E, Yang Y, Li J, Chen S, Shen WJ, Azhar S, Guo Z, Hu Z. Biochim Biophys Acta Mol Cell Biol Lipids; 2020 May 16; 1865(5):158640. PubMed ID: 31988048 [Abstract] [Full Text] [Related]
10. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease. Lin Y, Ding D, Huang Q, Liu Q, Lu H, Lu Y, Chi Y, Sun X, Ye G, Zhu H, Wei J, Dong S. Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep 16; 1862(9):869-882. PubMed ID: 28483554 [Abstract] [Full Text] [Related]
11. Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p. Zhang B, Li H, Li D, Sun H, Li M, Hu H. Gene; 2019 Jun 05; 700():139-148. PubMed ID: 30898698 [Abstract] [Full Text] [Related]
12. MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis. Wu H, Zhang T, Pan F, Steer CJ, Li Z, Chen X, Song G. J Hepatol; 2017 Apr 05; 66(4):816-824. PubMed ID: 28025059 [Abstract] [Full Text] [Related]
13. MiR-18 regulates lipid metabolism of non-alcoholic fatty liver disease via IGF1. Yang H, Zhang B, Yu C. Cell Mol Biol (Noisy-le-grand); 2024 Apr 28; 70(4):237-241. PubMed ID: 38678599 [Abstract] [Full Text] [Related]
14. Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy. Stacchiotti A, Grossi I, García-Gómez R, Patel GA, Salvi A, Lavazza A, De Petro G, Monsalve M, Rezzani R. Cells; 2019 Sep 08; 8(9):. PubMed ID: 31500354 [Abstract] [Full Text] [Related]
15. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice. Zhu LH, Wang A, Luo P, Wang X, Jiang DS, Deng W, Zhang X, Wang T, Liu Y, Gao L, Zhang S, Zhang X, Zhang J, Li H. J Hepatol; 2014 May 08; 60(5):1046-54. PubMed ID: 24445216 [Abstract] [Full Text] [Related]
17. MiR-17 family-mediated regulation of Pknox1 influences hepatic steatosis and insulin signaling. Ye D, Lou G, Zhang T, Dong F, Liu Y. J Cell Mol Med; 2018 Dec 08; 22(12):6167-6175. PubMed ID: 30338914 [Abstract] [Full Text] [Related]
18. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. Long JK, Dai W, Zheng YW, Zhao SP. Mol Med; 2019 Jun 13; 25(1):26. PubMed ID: 31195981 [Abstract] [Full Text] [Related]
19. FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease. Zhang C, Chen F, Feng L, Shan Q, Zheng GH, Wang YJ, Lu J, Fan SH, Sun CH, Wu DM, Li MQ, Hu B, Wang QQ, Zhang ZF, Zheng YL. Mol Med; 2019 Jun 18; 25(1):29. PubMed ID: 31215394 [Abstract] [Full Text] [Related]
20. Aerobic endurance training improves nonalcoholic fatty liver disease (NAFLD) features via miR-33 dependent autophagy induction in high fat diet fed mice. Ghareghani P, Shanaki M, Ahmadi S, Khoshdel AR, Rezvan N, Meshkani R, Delfan M, Gorgani-Firuzjaee S. Obes Res Clin Pract; 2018 Jun 18; 12(Suppl 2):80-89. PubMed ID: 28163011 [Abstract] [Full Text] [Related] Page: [Next] [New Search]